The Use of Drugs in Combination for the Treatment of Cancer
- 10 May 1973
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 288 (19) , 998-1006
- https://doi.org/10.1056/nejm197305102881905
Abstract
INTEREST in the use of drugs in combination tor the treatment of cancer is not a new phenomenon. It stems from the inability to obtain entirely satisfactory results when available agents are given singly. Theoretical interest in this area can be traced back more than 10 years with the work of Goldin,1 Potter,2 Elion,3 Skipper,4 and Lepage and Sartorelli.5 6 7 The first major clinical effort began in the late 1950's, with the use of drug combinations in the treatment of neoplasms of the testes and other tumors.8 , 9 The current intensity of the interest in this approach derives from two major sources. . . .Keywords
This publication has 37 references indexed in Scilit:
- Combination Chemotherapy in Generalized Hodgkin's DiseaseBMJ, 1970
- Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimensJAMA, 1969
- Survival of children with neuroblastoma treated with combination chemotherapyThe Journal of Pediatrics, 1968
- ACUTE LYMPHOBLASTIC LEUKÆMIA TREATED WITH A COMBINATION OF PREDNISONE, VINCRISTINE, AND RUBIDOMYCINThe Lancet, 1967
- Dactinomycin in Wilms' tumorJAMA, 1967
- Role of dactinomycin in the improved survival of children with Wilms' tumorJAMA, 1966
- Combination Chemotherapy of Childhood NeuroblastomaJAMA, 1965
- Combined Vinblastine and Chlorambucil Therapy of Hodgkin's DiseaseAnnals of Internal Medicine, 1965
- Potentiation by inhibition of drug degradation : 6-substituted purines and xanthine oxidaseBiochemical Pharmacology, 1963
- The Treatment of Retinoblastoma by X-Ray and Triethylene MelamineArchives of Ophthalmology (1950), 1958